AstraZeneca

AstraZeneca articles from Informachine.
AstraZeneca acquires EsoBiotec in $1 bn deal

AstraZeneca acquires EsoBiotec in $1 bn deal

18 Mar 2025

British-Swedish multinational pharmaceutical and biotechnology company AstraZenica on Monday announced the acquisition of biotechnology company EsoBiotech in a $1 billion transaction

AstraZeneca starts global recall of its controversial Covid 19 vaccine

AstraZeneca starts global recall of its controversial Covid 19 vaccine

08 May 2024

Days after admitting that its Covid 19 vaccine could cause blood clot in some people, British-Swedish pharmaceutical company AstraZeneca

AstraZeneca to buy China's Gracell Biotechnologies for $1.2 bn

AstraZeneca to buy China's Gracell Biotechnologies for $1.2 bn

27 Dec 2023

Anglo-Swedish multinational pharmaceutical and biotechnology company AstraZeneca has agreed to acquire China-based Gracell Biotechnologies Inc, for about $1.2 billion.

AstraZeneca to acquire CinCor Pharma in a deal worth $1,8 bn

11 Jan 2023

AstraZeneca to acquire biotech firm TeneoTwo in a deal worth more than $1.27 billion

08 Jul 2022

AstraZeneca to acquire Alexion in a $39 bn cash-and-stock deal

23 Dec 2020

India may grant emergency use authorisation for Oxford-AstraZeneca Covid-19 vaccine: report

24 Nov 2020

AstraZeneca Covid-19 vaccine trial volunteer in Brazil dies; testing to continue

26 Oct 2020

Sun Pharma licenses AstraZeneca to sell its oncology drugs in China

06 Nov 2019

AstraZeneca and Merck claim Japanese approval for anti-cancer drug Lynparza

20 Jun 2019

Stay ahead with Informachine News Trackers! Follow your selected sources, track business news with relevant keywords, and organize seamlessly using labels and bookmarks.

Get the business updates you need, fast, focused, and tailored just for you. Save time, stay informed, and never miss a beat!

Start your free subscription today!

Latest articles on AstraZeneca from Informachine

Imfinzi plus Imdelltra demonstrated a statistically significant and highly clinically meaningful improvement in overall survival and progression-free survival in 1st-line extensive-stage small cell lung cancer

09 Sep 2026

Tozorakimab demonstrated statistically significant and highly clinically meaningful reduction in COPD exacerbations in OBERON and TITANIA Phase III trials

09 Sep 2026

Etcamah in combination with a CDK4/6 inhibitor approved in the US for 1st-line advanced HR-positive breast cancer

09 Sep 2026

Enhertu plus pertuzumab approved in the EU as first new regimen in more than a decade for the 1st-line treatment of patients with HER2-positive metastatic breast cancer

09 Sep 2026

AstraZeneca completes global license agreement for oral EGFR inhibitor Zegfrovy for lung cancer

09 Sep 2026

Tezspire demonstrates positive Phase III results in eosinophilic esophagitis across both co-primary and all key secondary endpoints

27 Aug 2026

Enhertu demonstrated statistically significant and clinically meaningful improvement in progression-free survival as 1st-line treatment of patients with HER2-mutant advanced non-small cell lung cancer in DESTINY-Lung04 Phase III trial

17 Aug 2026

Update on eVOLVE-Lung02 Phase III trial of volrustomig plus chemotherapy in metastatic non-small cell lung cancer

17 Aug 2026

Tagrisso plus Orpathys demonstrated statistically significant and clinically meaningful improvements in progression-free and overall survival in MET-driven EGFR-mutated lung cancer after progression on Tagrisso

17 Aug 2026

Datroway approved in the EU as only TROP2-directed medicine with overall survival benefit for the 1st-line treatment of patients with metastatic TNBC who are not candidates for immunotherapy

31 Jul 2026

Start your free subscription today!

View details about the software product Informachine News Trackers

Latest articles

Lohum starts Zimbabwe lithium operations with first ore shipment

 Lohum starts Zimbabwe lithium operations with first ore shipment

OpenAI deepens Samsung alliance on next-generation AI chips

 OpenAI deepens Samsung alliance on next-generation AI chips

Google commits €13 billion to Finnish AI infrastructure with nuclear deal

 Google commits €13 billion to Finnish AI infrastructure with nuclear deal

Texas audits 474 GW data centre queue as US tackles speculative power demand

 Texas audits 474 GW data centre queue as US tackles speculative power demand

China issues overseas competition guidelines for automakers as exports expand

 China issues overseas competition guidelines for automakers as exports expand

Private investment strengthens as India records 7.8% GDP growth in Q1

 Private investment strengthens as India records 7.8% GDP growth in Q1

Switzerland keeps October 1 transparency register launch despite hack fears

 Switzerland keeps October 1 transparency register launch despite hack fears

US 10-year yield tests 4.75% as hawkish Fed signals lift rate bets

 US 10-year yield tests 4.75% as hawkish Fed signals lift rate bets

EPA weighs refinery waivers of up to 1.8 billion RINs amid farm backlash

 EPA weighs refinery waivers of up to 1.8 billion RINs amid farm backlash